Compositions and methods for treating amyotrophic lateral sclerosis
Abstract:
Methods for modulating expression of SMN1 and/or SMN2 in cells obtained from subjects having ALS or in subjects having ALS using single stranded oligonucleotides are provided. Methods for treating ALS using single stranded oligonucleotides are also provided.
Information query
Patent Agency Ranking
0/0